| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure.
|
Am J Med
|
2013
|
3.46
|
|
2
|
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management.
|
Can J Cardiol
|
2006
|
3.20
|
|
3
|
Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial.
|
Circulation
|
2013
|
2.90
|
|
4
|
Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ≥120 milliseconds.
|
Circulation
|
2011
|
2.36
|
|
5
|
Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.
|
Circulation
|
2003
|
2.16
|
|
6
|
Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial.
|
Int J Cardiol
|
2007
|
2.05
|
|
7
|
Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure.
|
Circulation
|
2010
|
1.73
|
|
8
|
Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial.
|
Circulation
|
2010
|
1.72
|
|
9
|
Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.
|
Can J Cardiol
|
2007
|
1.70
|
|
10
|
Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD).
|
Circulation
|
2003
|
1.69
|
|
11
|
Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study.
|
Eur J Heart Fail
|
2010
|
1.55
|
|
12
|
Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
|
Circ Heart Fail
|
2012
|
1.48
|
|
13
|
Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure.
|
Eur Heart J
|
2003
|
1.44
|
|
14
|
Acute heart failure: perspectives from a randomized trial and a simultaneous registry.
|
Circ Heart Fail
|
2012
|
1.42
|
|
15
|
Myocyte growth, repair, and oxidative stress following pediatric heart transplantation.
|
Pediatr Transplant
|
2014
|
1.37
|
|
16
|
A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study.
|
Eur Heart J
|
2009
|
1.34
|
|
17
|
Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study.
|
J Card Fail
|
2008
|
1.32
|
|
18
|
A propensity-matched study of elevated jugular venous pressure and outcomes in chronic heart failure.
|
Am J Cardiol
|
2009
|
1.24
|
|
19
|
Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial.
|
CMAJ
|
2005
|
1.23
|
|
20
|
Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure.
|
Am J Cardiol
|
2011
|
1.19
|
|
21
|
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.
|
Can J Cardiol
|
2008
|
1.15
|
|
22
|
Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial.
|
Am J Cardiol
|
2008
|
1.14
|
|
23
|
[Battlefield Blues: Ambivalence about treatment among military Veterans with depression].
|
Can Fam Physician
|
2009
|
1.12
|
|
24
|
Barium block of Kir2 and human cardiac inward rectifier currents: evidence for subunit-heteromeric contribution to native currents.
|
Cardiovasc Res
|
2003
|
1.12
|
|
25
|
Impact of better adherence to statin agents in the primary prevention of coronary artery disease.
|
Eur J Clin Pharmacol
|
2009
|
1.11
|
|
26
|
Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial).
|
Am J Cardiol
|
2010
|
1.08
|
|
27
|
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials.
|
Can J Cardiol
|
2009
|
1.04
|
|
28
|
Digoxin and reduction of heart failure hospitalization in chronic systolic and diastolic heart failure.
|
Am J Cardiol
|
2008
|
0.96
|
|
29
|
Isolated diastolic hypotension and incident heart failure in older adults.
|
Hypertension
|
2011
|
0.96
|
|
30
|
Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure.
|
PLoS One
|
2010
|
0.95
|
|
31
|
Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms.
|
PLoS One
|
2012
|
0.94
|
|
32
|
Effect of serum insulin on the association between hyperuricemia and incident heart failure.
|
Am J Cardiol
|
2010
|
0.92
|
|
33
|
Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves.
|
Am J Cardiol
|
2010
|
0.92
|
|
34
|
Impact of adherence to statins on chronic heart failure in primary prevention.
|
Br J Clin Pharmacol
|
2008
|
0.91
|
|
35
|
High-intensity interval exercise in chronic heart failure: protocol optimization.
|
J Card Fail
|
2011
|
0.91
|
|
36
|
An open-label study of nefazodone treatment of major depression in patients with congestive heart failure.
|
Can J Psychiatry
|
2003
|
0.91
|
|
37
|
Decreased heart rate recovery after exercise in patients with congestive heart failure: effect of beta-blocker therapy.
|
J Card Fail
|
2003
|
0.91
|
|
38
|
2001 Canadian Cardiovascular Society Consensus Conference on cardiac transplantation.
|
Can J Cardiol
|
2003
|
0.90
|
|
39
|
Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials.
|
Am Heart J
|
2006
|
0.90
|
|
40
|
Ten renin-angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure.
|
Br J Clin Pharmacol
|
2008
|
0.89
|
|
41
|
Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting.
|
Value Health
|
2009
|
0.88
|
|
42
|
Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation.
|
Am J Med
|
2013
|
0.87
|
|
43
|
Adherence level of antihypertensive agents in coronary artery disease.
|
Br J Clin Pharmacol
|
2010
|
0.87
|
|
44
|
Heart rate recovery--a potential marker of clinical outcomes in heart failure patients receiving beta-blocker therapy.
|
Can J Cardiol
|
2007
|
0.87
|
|
45
|
Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
|
Am J Cardiol
|
2005
|
0.86
|
|
46
|
Rheumatic heart disease and risk of incident heart failure among community-dwelling older adults: a prospective cohort study.
|
Ann Med
|
2011
|
0.86
|
|
47
|
An Internet-Based Counseling Intervention With Email Reminders that Promotes Self-Care in Adults With Chronic Heart Failure: Randomized Controlled Trial Protocol.
|
JMIR Res Protoc
|
2014
|
0.85
|
|
48
|
Pharmacokinetics in stable heart transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.
|
J Heart Lung Transplant
|
2011
|
0.84
|
|
49
|
Right ventricular ejection fraction <20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients.
|
Int J Cardiol
|
2011
|
0.84
|
|
50
|
Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.
|
Eur J Heart Fail
|
2012
|
0.84
|
|
51
|
Association between renal function and CYP3A5 genotype in heart transplant recipients treated with calcineurin inhibitors.
|
J Heart Lung Transplant
|
2010
|
0.83
|
|
52
|
Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial.
|
J Heart Lung Transplant
|
2007
|
0.83
|
|
53
|
Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST]).
|
Am Heart J
|
2010
|
0.82
|
|
54
|
Effect of warfarin on outcomes in septuagenarian patients with atrial fibrillation.
|
Am J Cardiol
|
2011
|
0.82
|
|
55
|
Evaluation of resynchronization therapy for heart failure in patients with a QRS duration greater than 120 ms (GREATER-EARTH) trial: rationale, design, and baseline characteristics.
|
Can J Cardiol
|
2011
|
0.82
|
|
56
|
Relationship between left and right ventricular ejection fractions in chronic advanced systolic heart failure: insights from the BEST trial.
|
Eur J Heart Fail
|
2010
|
0.82
|
|
57
|
Orthostatic hypotension and incident heart failure in community-dwelling older adults.
|
J Gerontol A Biol Sci Med Sci
|
2013
|
0.82
|
|
58
|
Association between smoking and outcomes in older adults with atrial fibrillation.
|
Arch Gerontol Geriatr
|
2011
|
0.81
|
|
59
|
Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving β-blockers: insights from the BEST trial.
|
Int J Cardiol
|
2011
|
0.81
|
|
60
|
Effect of left ventricular assist device bridging to transplantation on donor waiting time and outcomes in Canada.
|
Can J Cardiol
|
2004
|
0.81
|
|
61
|
Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial.
|
Int J Cardiol
|
2012
|
0.80
|
|
62
|
Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy.
|
Am J Cardiol
|
2005
|
0.80
|
|
63
|
Successful explantation of a left ventricular assist device following acute fulminant myocarditis.
|
Can J Cardiol
|
2006
|
0.80
|
|
64
|
Hemodynamic and clinical benefits associated with chronic sildenafil therapy in advanced heart failure: experience of the Montréal Heart Institute.
|
Can J Cardiol
|
2011
|
0.79
|
|
65
|
Reduced pulmonary clearance of endothelin in congestive heart failure: a marker of secondary pulmonary hypertension.
|
J Card Fail
|
2004
|
0.79
|
|
66
|
Cardiac remodeling with rhythm versus rate control strategies for atrial fibrillation in patients with heart failure: insights from the AF-CHF echocardiographic sub-study.
|
Int J Cardiol
|
2011
|
0.79
|
|
67
|
Effects of AGTR1 A1166C gene polymorphism in patients with heart failure treated with candesartan.
|
Ann Pharmacother
|
2008
|
0.79
|
|
68
|
Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
|
J Card Fail
|
2007
|
0.79
|
|
69
|
Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.
|
Can J Cardiol
|
2011
|
0.79
|
|
70
|
Temporal increases in subclinical levels of inflammation are associated with adverse clinical outcomes in patients with left ventricular dysfunction.
|
J Card Fail
|
2006
|
0.78
|
|
71
|
Incidence and prognosis of cancer following heart transplantation using RATG induction therapy.
|
Transpl Int
|
2005
|
0.78
|
|
72
|
An unusual case of giant cell myocarditis missed in a Heartmate-2 left ventricle apical-wedge section: a case report and review of the literature.
|
J Cardiothorac Surg
|
2013
|
0.77
|
|
73
|
Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol).
|
Am J Cardiol
|
2003
|
0.77
|
|
74
|
Lack of long-term benefits of a 6-month heart failure disease management program.
|
J Card Fail
|
2007
|
0.77
|
|
75
|
Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure.
|
Am Heart J
|
2005
|
0.77
|
|
76
|
Systolic blood pressure and mortality in patients with atrial fibrillation and heart failure: insights from the AFFIRM and AF-CHF studies.
|
Eur J Heart Fail
|
2014
|
0.77
|
|
77
|
Long-term evolution, secular trends, and risk factors of renal dysfunction following cardiac transplantation.
|
Transpl Int
|
2014
|
0.76
|
|
78
|
Impact of ezetimibe on cholesterol subfractions in dyslipidemic cardiac transplant recipients receiving statin therapy.
|
Clin Transplant
|
2009
|
0.76
|
|
79
|
Cold temperature impairs maximal exercise performance in patients with heart failure: attenuation by acute ACE inhibitor therapy.
|
Can J Cardiol
|
2002
|
0.76
|
|
80
|
Cardiac transplantation for hypertrophic cardiomyopathy: a valid therapeutic option.
|
J Heart Lung Transplant
|
2004
|
0.76
|
|
81
|
Results following implantation of mechanical circulatory support systems: the Montreal Heart Institute experience.
|
Can J Cardiol
|
2009
|
0.75
|
|
82
|
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 4--treatment.
|
Congest Heart Fail
|
2002
|
0.75
|
|
83
|
Comparison of the beta blocker bucindolol in younger versus older patients with heart failure.
|
Am J Cardiol
|
2002
|
0.75
|
|
84
|
Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).
|
Can J Cardiol
|
2008
|
0.75
|
|
85
|
Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring--further insights from SOLVD.
|
Can J Cardiol
|
2008
|
0.75
|
|
86
|
Two decades of cardiac transplantation at the Montreal Heart Institute.
|
Can J Cardiol
|
2008
|
0.75
|
|
87
|
PRKCB is associated with calcineurin inhibitor-induced renal dysfunction in heart transplant recipients.
|
Pharmacogenet Genomics
|
2012
|
0.75
|
|
88
|
Effects of reading media on reading comprehension in health professional education: a systematic review protocol.
|
JBI Evid Synth
|
2020
|
0.75
|
|
89
|
A cardiac and a kidney transplant patient above 6000 meters in Bolivia.
|
Wilderness Environ Med
|
2009
|
0.75
|
|
90
|
Cerebral And Cardiac Hemodynamics During Exercise Are Related To Cognitive Function In Heart Transplant Recipients: 921 Board #237 June 1, 2: 00 PM - 3: 30 PM.
|
Med Sci Sports Exerc
|
2016
|
0.75
|
|
91
|
Persistent elevation of VEGF and prostacyclin following poor cardiopulmonary adaptation to high altitude.
|
Wilderness Environ Med
|
2009
|
0.75
|
|
92
|
Enantioselective quantification of carvedilol in human plasma by HPLC in heavily medicated heart failure patients.
|
J Pharm Biomed Anal
|
2010
|
0.75
|
|
93
|
Forearm reactive hyperemic blood flow and arm-cranking exercise capacity in healthy and heart failure subjects.
|
J Card Fail
|
2002
|
0.75
|